Allergan receives FTC clearance to buy Tobira Therapeutics
MLex Summary: Allergan received the go-ahead from the US Federal Trade Commission to buy Tobira Therapeutics, which develops products to treat liver diseases, Allergan said in a statement Wednesday. The FTC cleared...To view the full article, register now.
Already a subscriber? Click here to view full article